VPSENSE

Overview & Mission

VPSense is a breakthrough wearable, noninvasive device designed to detect life-threatening blood clots at the exact moment of formation.

By fusing Quantum Magnetic Flux sensing with Integrated Doppler, we monitor the physiological progression of a clot non-invasively across three critical phases:

• Phase 1: Vascular Spasm (0–10 sec) – Immediate detection of sudden drops in blood flow velocity.
• Phase 2: Platelet Plug (30–60 sec) – Identification of localized increases in cellular density during platelet activation.
• Phase 3: The "Red Clot" (2–6 min) – Capturing the distinct magnetic flux signature of iron (hemoglobin) trapped within the fibrin mesh.

Our integrated Doppler & Quantum sensor provides instant validation of mechanical blockages. By replacing invasive blood tests and bulky hospital imaging with a single wearable, we provide 100% diagnostic closure and life-saving early alerts for Stroke and DVT.

The Problem

Stroke is the second leading cause of death & Disability globally, according to the World Health Organization (WHO). Early detection is critical to minimizing brain damage and improving recovery outcomes.

Market & Target Audience

• Model: B2B - Disposable & Subscription (CPT code 99454).
• Market Size: Stroke in the digital health sector is valued at $40B.
• Growth: The global Stroke market growth rate presents a CAGR of 7.7% from 2021 to 2031.
• Target Audience: Patients at high risk, those who experienced a first stroke, or post Coronary artery bypass surgery.